Welcome to Tip’d, a social media site for finance, investing, and business topics. Want to participate? » Join Tip’d now! or read our FAQ.
Abbott Laboratories (ABT) has agreed to buy the drug unit of Belgian firm Solvay for $6.6 billion in cash. The deal could include additional milestone payments and liabilities later on.
Save & Share
Spam? Topple this!
Save & Share
Spam? Topple this!
MediaMan
Comments
Want to leave a comment on this story? Login or join Tip'd to comment.